De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Trans Recip
Conditions: Kidney Transplant; Complications; CMV Interventions: Drug: Letermovir 480 mg once daily; Other: Historical/Control Sponsors: Virginia Commonwealth University; Merck Sharp & Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
Donor Derived Cell-free DNA and Rejection of Kidney Allografts
Condition: Kidney Rejection Transplant Intervention: Diagnostic Test: Donor-derived cell-free DNA Sponsor: Paris Translational Research Center for Organ Transplantation Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2023 Category: Research Source Type: clinical trials